EX-16.1 2 ex16-1.htm

 

Exhibit 16.1

 

April 21, 2025

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Dear Sir/Madam:

 

We have read Jupiter Neurosciences, Inc.’s statements included under Item 4.01 of its Form 8-K filed on April 21, 2025 and we agree with such statements concerning our firm.

 

Very truly yours,

 

/s/ Assurance Dimensions, LLC

Tampa, Florida